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Abstract
Hypertension is a modiﬁable risk factor for cardiovascular disease, but it remains the main cause of death in Luxembourg. We aimed
to estimate the current prevalence of hypertension, associated risk factors, and its geographic variation in Luxembourg.
Cross-sectional, population-based data on 1497 randomly selected Luxembourg residents aged 25 to 64 years were collected as
part of the European Health Examination Survey from 2013 to 2015. Hypertension was deﬁned as systolic/diastolic blood pressure
≥140/90mmHg, self-report of a physician diagnosis or on antihypertensivemedication. Standard andBayesian regressionswere used
to examine associations between hypertension and covariates, and also geographic distribution of hypertension across the country.
Nearly 31% of Luxembourg residents were hypertensive, and over 70% of those were either unaware of their condition or not
adequately controlled. The likelihood of hypertension was lower in men more physically active (odds ratio [95% credible region] 0.6
[0.4, 0.9]) and consuming alcohol daily (0.3 [0.1, 0.8]), and higher in men with a poor health perception (1.6 [1.0, 2.7]) and in women
experiencing depressive symptoms (1.8 [1.3, 2.7]). There were geographic variations in hypertension prevalence across cantons and
municipalities. The highest odds ratio was observed in themost industrialized region (South-West) (1.2 [0.9, 1.6]) with a positive effect
at 90% credible region.
In Luxembourg, the vastmajority of peoplewith hypertension are either unaware of their condition or not adequately controlled,which
constitutes a major, neglected public health challenge. There are geographic variations in hypertension prevalence in Luxembourg,
hence the role of individual and regional risk factors along with public health initiatives to reduce disease burden should be considered.
Abbreviations: BMI = body mass index, CR = 95% credible region, DALYS = disability-adjusted life-years, EHES-LUX =
European Health Examination Survey in Luxembourg, EU = European, MCMC =Markov Chain Monte Carlo technique, OR = odds
ratio, PHQ-9 = Patient Health Questionnaire, POR = posterior odds ratio, WHO = World Health Organization.
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11. Introduction
High blood pressure plays an important role in the etiology of
cardiovascular disease, a leading cause of mortality worldwide.[1]
Based on recent estimates, high systolic blood pressure is the
second most important risk factor of death after diet worldwide,
causing 9.6% of global disability-adjusted life-years (DALYs).[2]
Currently, nearly 22% of the world adult population are
hypertensive, with an increasing trend in prevalence in low and
middle-income countries.[3,4] Studies have shown that hyperten-
sion can be prevented through a healthy diet with low salt intake,
regular physical activity, normal body weight, abstention from
smoking, and limited alcohol consumption.[5–9] Recent evidence
also highlights the positive effects of quality of life, good mental
health, and other health-related behaviors such as sleep duration
and quality on blood pressure values.[10–14] The asymptomatic
characteristics of hypertension still account for a considerable
public health challenge undermining patient awareness and
optimal management. Furthermore, as a backdrop of increasing
life expectancy, the lifetime risk of hypertension is expected to
increase in aging populations.[3,15]
Luxembourg is a high-income country located between
Belgium, Germany, and France, and is divided into 106 legal
administratively autonomous communes (also known as munici-
palities) that are grouped into 12 cantons (areas). Characteristic
of Luxembourg is its cultural diversity, with nearly 45% of the
population being foreign nationals in 2015 (16.4% Portuguese,
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countries).[16] This makes Luxembourg a unique country in
Europe with a complex and heterogeneous health proﬁle
compared with neighbouring countries. Currently, cardiovascu-
lar diseases remain the leading cause of death in Luxembourg
(31.8%) followed by cancer (28.1%).[17] Heart diseases (8.6%)
and strokes (8.3%) are the most common types of registered
cardiovascular events.[18] In a previous study conducted in
Luxembourg in 2007 to 2009, the prevalence of hypertension in
adults aged 18 to 69 was around 34% (41.9% of men and 27.1%
of women), with an elevated percentage of individuals who were
either unaware or not properly controlled.[19,20]
The aim of the present study was to estimate the current
prevalence of hypertension, individual risk factors associated
with hypertension, and the level of awareness and adequate
control among those who suffer from this condition in
Luxembourg. We also examined the geographic variations of
hypertension prevalence in the country after adjusting for a range
of individual risk factors including health-related behaviors,
socioeconomic characteristics, body mass index (BMI), depres-
sive symptoms, and health perception.
2. Methods
2.1. Study design, population, and recruitment
Data were derived from the European Health Examination
Survey in Luxembourg (EHES-LUX), a cross-sectional popula-Figure 1. Flow chart that show
2tion-based survey conducted between February 2013 and
January 2015. The target sample included residents of the
Grand-Duchy of Luxembourg aged 25 to 64 years who agreed to
participate. Institutionalized individuals (e.g., hospitals, older
homes, and jails) were excluded. All participants included in the
study signed an informed consent. Potential participants were
randomly sampled in a 1-stage sampling procedure and stratiﬁed
by age, sex, and district of residence. The sample was drawn from
the national population register by the “Inspection générale de la
sécurité sociale.” Randomly selected individuals (N=6475)
received an invitation letter to participate in the study with a
response card and a prepaid envelope. As time passed between
obtaining the sample selection until the beginning of the project,
143 individuals did not meet the selection criteria at the start of
the study (e.g., they had since changed their country of residence
or they were more than 64 years old) and thus were excluded
from the study (ﬁrst, second, third, and fourth exclusion).
Therefore, among 6475, 6332 individuals were eligible for the
study. In all, 1529 individuals agreed to participate (participation
rate of 24.1%). Of them, 1517 had blood pressure measurements
and 1526 reported their hypertension status and medication; 21
pregnant women were excluded from the present analysis. The
ﬁnal sample size for this analysis comprised 1497 individuals
with blood pressure measurements and/or self-reported hyper-
tension diagnosis and medication (Fig. 1). The participation rate
was deﬁned as the total number of participants (N=1529)
divided by all eligible cases (N=6332).[21] From each participant,s the recruitment process.
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examinations, and biological samples were collected by trained
nurses. Examinations were done in 3 different sites covering the
whole country: the Centre de Recherche Public de la Santé
(Strassen)—Center of the country, the Centre Pontalize (Ettel-
bruck)—North of the country, and the Centre Hospitalier Emile
Mayrisch (Esch-sur-Alzette)—South of the country. A clinical
committee evaluated the examination results. In case of
abnormal-severe values, the participant’s medical doctor was
informed orally. The study was approved by the national
research ethics committee (Comité national d’éthique de
recherche) and notiﬁed to the Commission nationale pour la
protection des données, the Luxemburgish national commission
for data protection.
2.2. Hypertension
The study nurses measured participants’ blood pressure 3 times in
a sitting position and on the right arm using an OMRON MX3
Plus or M6 Confort electronic blood pressure manometer, with
the arm cuffs size adapted to the participant’s arm circumference.
Blood pressure was measured after the participants rested for
5minutes and with intervals of 1minute between each measure-
ment. We calculated both systolic and diastolic pressures as the
mean of their second and third measurements. Hypertension was
deﬁned as systolic/diastolic blood pressure of ≥140/90mm Hg,
self-report of a physician diagnosis, or on antihypertensive
medication. Hypertensive participants who reported having
being diagnosed as hypertensive by a physician or being under
medication for hypertension were classiﬁed as aware. Aware
hypertensive participants with systolic/diastolic blood pressure
≥140/90mm Hg were classiﬁed as uncontrolled.2.3. Covariates
Socioeconomic position of each participant was examined using
education (primary, secondary, and tertiary education complet-
ed) and job status (employed and unemployed). Sociodemo-
graphic characteristics included age, sex, country of birth
(Luxembourg, Portugal, other European [EU] countries, and
other non-EU countries), and marital status (single vs married or
in a civil union). Lifestyles included smoking, alcohol consump-
tion, vegetable and fruit consumption, physical activity, and sleep
duration during both working and nonworking days. Smoking
was classiﬁed as having never smoked, occasional smoker, daily
smoker, and ex-smoker. Alcohol consumption was classiﬁed
based on the last year of consumption: no alcohol consumption,
ex-drinkers, irregular alcohol consumption (less than once a
month), regular alcohol consumption (drink alcohol at least
once a week), and daily alcohol consumption. Vegetable and
fruit consumption was classiﬁed based on the World Health
Organization (WHO) recommendations of 5portions/d: low (<1
portion/d); moderate (1–4portions/d); high (≥5portions/d).
Physical activity was deﬁned based on the frequency and total
time of sports, ﬁtness, and/or recreational activities for at least 10
consecutive minutes. It was classiﬁed as follows: never, moderate
(1–3h/wk), and high (>3h/wk). Sleep duration was categorized
into sleep hours as follows:6hours, 7 to 8hours, and ≥9hours.
Depressive symptoms were measured with the Patient Health
Questionnaire (PHQ)-9 and deﬁned as presence of depressive
symptoms (≥5 PHQ-9 score) or not (<5 PHQ-9 score).[22]
Diabetes mellitus was deﬁned as fasting glucose blood levels of
≥126mg/dL. Prediabetes was deﬁned as glucose blood levels3between ≥100mg/dL and <126mg/dL. Hypercholesterolemia
was deﬁned as cholesterol levels of ≥200mg/dL, self-report of
a physician diagnosis, or on medication to reduce cholesterol
levels.2.4. Statistical data analysis
Means and frequencies were used to describe the general
characteristics of the sample population. We used a chi-square
test or Student t test to analyze associations between the
prevalence of hypertension and its potential risk factors.
Multivariable logistic regression models were used to examine
the association between hypertension and covariates. Observa-
tions were weighted and analyses were performed using survey
package in R. In a further step to account for geographic
variations in the prevalence of hypertension (commune and
canton levels), we applied a uniﬁed approach to account for
possible nonlinear effects of continuous risk factors.We applied a
geo-additive semiparametric mixed model and employed a fully
Bayesian approach using Markov Chain Monte Carlo (MCMC)
techniques for inference and model checking.[23,24] The response
variable was deﬁned as yi=1, if “hypertensive” and yi=0,
otherwise. The standard measure of effect was the posterior odds
ratio (POR) and 95% credible region (CR). Multivariate
Bayesian geo-additive regression models were used to evaluate
the signiﬁcance of the POR determined for the ﬁxed, nonlinear
effects, and spatial effects. PORs were represented using a color
degradation ranging from green (low risk) to red (high risk)
through yellow (no risk). Statistically signiﬁcant positive,
negative, and nonsigniﬁcant spatial effects were represented in
black, gray, and white, respectively. Despite the low participation
rate, the distribution of participants by canton was similar to the
total population. Moreover, the Bayesian methods allowed to
include the correlation structure and accounted for the
dependence of neighboring cantons (community) in the model.
The model also permitted “borrowing strength” from neighbor-
ing areas to obtain estimates that may, on their own, have
inadequate sample sizes and gave more reliable estimates of the
hypertension risk factors. P values lower than 0.05 were
considered as statistically signiﬁcant. The analysis was carried
out using version 2.0.1 of the Bayes X software package,
which allows Bayesian inference based on MCMC simulation
techniques.[25]3. Results
General participant characteristics are described in Table 1.
Nearly a third of participants were hypertensive (31.46%). Half
of those were unaware of their condition, and of those who were
aware, almost 50% were not adequately controlled. More than
half of the participants were overweight or obese and, on average,
in their forties (45.04±10.07), with a slight predominance of
female participants. Almost half of participants were born
outside of Luxembourg. More than 20% of the sample
population were smokers and around 90% consumed alcohol.
One-third of the participants consumed less than 1 daily portion
of fruits and vegetables, and around 40% of participants had not
engaged in sports, ﬁtness, or leisure activities. Nearly 13% of the
participants slept 6hours or less during rest days and over 24%
of participants perceived their health as poor or presented
depressive symptoms. Nearly one-third of the participants
(31.0%) had glucose dysregulation (either prediabetes or
diabetes) and 62% of the participants had hypercholesterolemia.
Table 1
General characteristics of the sample population (EHES-LUX, N=
1497).
N (%) / Mean±SD
Hypertension
Normotensive 1026 (68.54)
Hypertensive 471 (31.46)
Hypertension awareness
Normotensive 1026 (68.58)
Hypertensive not aware 209 (13.97)
Hypertensive aware 261 (17.45)
Controlled 137 (53.10)
Not controlled 121 (46.90)
Age, y 45.04±10.07
Sex
Women 719 (48.03)
Men 778 (51.97)
Country of birth
Luxembourg 785 (52.44)
Portugal 219 (14.63)
Other EU countries 342 (22.85)
Other non-EU countries 151 (10.09)
Education
Primary 372 (24.93)
Secondary 575 (38.54)
Tertiary 545 (36.53)
Job status
Working 1148 (76.74)
Not working 348 (23.26)
Marital status
Married or in a civil union 987 (65.93)
Single 510 (34.07)
Smoking
Never smoke 815 (54.52)
Ex-smokers 334 (22.34)
Occasionally 79 (5.28)
Everyday 267 (17.86)
Alcohol (last year)
Never 109 (7.29)
Ex-drinkers 64 (4.28)
Irregularly 437 (29.23)
Regularly 698 (46.69)
Everyday 187 (12.51)
Vegetable and fruit consumption
<1 portion/d 461 (30.84)
1–4 portions/d 800 (53.51)
≥5 portions/d 234 (15.65)
Physical activity
Never 608 (40.75)
3h/wk 505 (33.85)
>3h/wk 379 (25.40)
Sleep duration, h
7–8 871 (58.42)
6 201 (13.48)
≥9 419 (28.10)
Depressive symptoms
∗
No 1134 (75.80)
Yes 362 (24.20)
Health perception
Good 1136 (75.94)
Not good 360 (24.06)
BMI, kg/m2 26.58±5.03
<25 639 (42.74)
25–30 551 (36.86)
≥30 305 (20.40)
Prediabetes
Normal 991 (68.96)
N (%) / Mean±SD
Prediabetes 393 (27.35)
Diabetes 53 (3.69)
Hypercholesterolemia
No 550 (37.98)
Yes 898 (62.02)
Percentages do not include missing values; missing values for individual covariates ranged from 1 to 6
observations for all variables except for prediabetes (60 missing values) and hypercholesterolemia (49
missing values).
BMI=body mass index, EHES-LUX=European Health Examination Survey in Luxembourg, EU=
European Union, N=number, SD= standard deviation, WC=waist circumference.
∗
Measured with the 9-Item Patient Health Questionnaire (PHQ-9 ≥5).
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and women (see Figure, Supplemental Content 1, http://links.
lww.com/MD/B251). Results show blood pressure values of
participants not taking antihypertensive medication. Among
female participants, the age-related increase in blood pressure
values was steeper around the menopausal transition, as
expected. The Supplemental Table (Supplemental Content 2,
http://links.lww.com/MD/B251) shows participant character-
istics by hypertension awareness, treatment, and control. Those
being unaware of their condition were younger, men, with no
depressive symptoms, with lower values of BMI and HbA1c,
employed, with a better health perception, and higher values of
total cholesterol. Of those participants who were aware of their
hypertension, nearly half were not controlled.
Characteristics of hypertensive and normotensive participants
are presented in Table 2 stratiﬁed by sex. Overall, men were more
likely to be hypertensive thanwomen. Hypertensive patients were
also more likely to be older, unemployed, not physically active,
overweight or obese, and with a poor health perception.
Education, alcohol consumption, sleep hours, and depressive
symptoms had a stronger effect in women than in men.
Hypertension was not related to vegetable and fruit consumption
or country of birth.
Figure 2 shows estimates of residual spatial effects for
hypertension risk by cantons (A) and communes (B) of
Luxembourg adjusted by individual covariates and geographical
location and stratiﬁed by sex (men: A1.1 and B1.1; women: A1.2
and B1.2). Overall, higher odds of hypertension were observed in
the South-Western region of the country. We observed a
statistically signiﬁcant positive spatial effect in this region at
90%CR and a higher variability when focusing on the commune
level, particularly among women.
Table 3 shows overall marginal and POR of hypertension
across covariates and stratiﬁed by sex. Being overweight and
obese were associated with higher odds of hypertension (2.07
[1.52, 2.83] and 5.59 [3.94, 7.92], respectively). Employed and
physically active participants were protected from hypertension
(0.71 [0.50, 0.99] and 0.69 [0.49, 0.97], respectively); however,
these associations were attenuated when stratiﬁed by sex and
disappeared in the posterior model with regard to job status (0.74
[0.52, 1.04]). As to physical activity, the posterior model shows
that having more than 3h/wk of physical activity had a protective
effect from hypertension, but only in men (0.60 [0.37, 0.92]). The
same posterior model also shows that in men the likelihood of
hypertension was lower in those who consumed alcohol and
higher in those with a poor health perception (1.63 [1.01, 2.69]),
whereas in women, experiencing depressive symptoms increased
the odds of hypertension (1.83 [1.27, 2.68]). One particular
variation observed in the posterior model was that in men,
Table 2
Characteristics of participants by hypertension status and stratiﬁed by sex (EHES-LUX, N=1497).
Total Men Women
Normotensive Hypertensive P
∗
Normotensive Hypertensive P
∗
Normotensive Hypertensive P
∗
Total 1026 (68.54) 471 (31.46) 430 (59.81) 289 (40.19) 596 (76.61) 182 (23.39)
Sex
Men 430 (59.81) 289 (40.19) <0.001
Women 596 (76.61) 182 (23.39)
Age, y 42.86±9.57 49.66±9.52 <0.001 42.72±9.52 48.51±9.30 <0.001 42.96±9.61 51.49±9.60 <0.001
Country of birth
Luxembourg 528 (67.26) 257 (32.74) 0.346 220 (56.85) 167 (43.15) 0.194 308 (77.39) 90 (22.61) 0.865
Portugal 147 (67.12) 72 (32.88) 63 (59.43) 43 (40.57) 84 (74.34) 29 (25.66)
Other EU countries 248 (72.51) 94 (27.49) 105 (66.88) 52 (33.12) 143 (77.30) 42 (22.70)
Other non-EU countries 103 (68.21) 48 (31.79) 42 (60.87) 27 (39.13) 61 (74.39) 21 (25.61)
Education
Primary 223 (59.95) 149 (40.05) <0.001 101 (57.39) 75 (42.61) 0.378 122 (62.24) 74 (37.76) <0.001
Secondary 388 (67.48) 187 (32.52) 154 (58.11) 111 (41.89) 234 (75.48) 76 (24.52)
Tertiary 411 (75.41) 134 (24.59) 174 (63.04) 102 (36.96) 237 (88.10) 32 (11.90)
Job status
Not working 191 (54.89) 157 (45.11) <0.001 55 (43.31) 72 (56.69) <0.001 136 (61.54) 85 (38.46) <0.001
Working 835 (72.74) 313 (27.26) 375 (63.45) 216 (36.55) 460 (82.59) 97 (17.41)
Marital status
Married or in a civil union 659 (66.77) 328 (33.23) 0.040 272 (56.55) 209 (43.45) 0.011 387 (76.48) 119 (23.52) 0.911
Single 367 (71.96) 143 (28.04) 158 (66.39) 80 (33.61) 209 (76.84) 63 (23.16)
Smoking
Never smoke 567 (69.57) 248 (30.43) 0.014 206 (59.20) 142 (40.80) 0.143 361 (77.30) 106 (22.70) 0.092
Ex-smokers 209 (62.57) 125 (37.43) 102 (54.55) 85 (45.45) 107 (72.79) 40 (27.21)
Occasionally 63 (79.75) 16 (20.25) 29 (69.05) 13 (30.95) 34 (91.89) 3 (8.11)
Everyday 186 (69.66) 81 (30.34) 92 (65.25) 49 (34.75) 94 (74.60) 32 (25.40)
Alcohol (last year)
Never 74 (67.89) 35 (32.11) <0.001 12 (50.00) 12 (50.00) 0.054 62 (72.94) 23 (27.06) <0.01
Ex-drinkers 40 (62.50) 24 (37.50) 12 (63.16) 7 (36.84) 28 (62.22) 17 (37.78)
Drink alcohol irregularly 322 (73.68) 115 (26.32) 89 (62.68) 53 (37.32) 233 (78.98) 62 (21.02)
Drink alcohol regularly 492 (70.49) 206 (29.51) 250 (62.81) 148 (37.19) 242 (80.67) 58 (19.33)
Drink alcohol everyday 97 (51.87) 90 (48.13) 67 (49.26) 69 (50.74) 30 (58.82) 21 (41.18)
Vegetable and fruit
consumption
<1 portion/d 308 (66.81) 153 (33.19) 0.512 180 (62.07) 110 (37.93) 0.424 128 (74.85) 43 (25.15) 0.504
1–4 portions/d 552 (69.00) 248 (31.00) 205 (59.42) 140 (40.58) 347 (76.26) 108 (23.74)
≥5 portions/d 166 (70.94) 68 (29.06) 45 (54.22) 38 (45.78) 121 (80.13) 30 (19.87)
Physical activity
Never 380 (62.50) 228 (37.50) <0.001 151 (52.25) 138 (47.75) <0.01 229 (71.79) 90 (28.21) 0.020
3h/wk 361 (71.49) 144 (28.51) 141 (62.39) 85 (37.61) 220 (78.85) 59 (21.15)
>3h/wk 282 (74.41) 97 (25.59) 136 (67.66) 65 (32.34) 146 (82.02) 32 (17.98)
Sleep duration
(not work days), h
7–8 610 (70.03) 261 (29.97) <0.001 269 (61.84) 166 (38.16) 0.099 341 (78.21) 95 (21.79) 0.015
6 117 (58.21) 84 (41.79) 48 (50.00) 48 (50.00) 69 (65.71) 36 (34.29)
≥9 297 (70.88) 122 (29.12) 112 (60.54) 73 (39.46) 185 (79.06) 49 (20.94)
BMI, kg/m2 25.46±4.39 29.03±5.41 <0.001 26.12±3.51 29.31±4.84 <0.001 24.99±4.88 28.58±6.21 <0.001
<25 534 (83.57) 105 (16.43) <0.001 179 (78.85) 48 (21.15) <0.001 355 (86.17) 57 (13.83) <0.001
25–30 361 (65.52) 190 (34.48) 204 (60.90) 131 (39.10) 157 (72.69) 59 (27.31)
≥30 129 (42.30) 176 (57.70) 46 (29.49) 110 (70.51) 83 (55.70) 66 (44.30)
Prediabetes
Normal 748 (75.48) 243 (24.52) <0.001 270 (67.00) 133 (33.00) <0.001 478 (81.29) 110 (18.71) <0.001
Prediabetes 225 (57.25) 168 (42.75) 134 (54.25) 113 (45.75) 91 (62.33) 55 (37.67)
Diabetes 11 (20.75) 42 (79.25) 8 (20.00) 32 (80.00) 3 (23.08) 10 (76.92)
Hypercholesterolemia
No 436 (79.27) 114 (20.73) <0.001 164 (68.91) 74 (31.09) <0.001 272 (87.18) 40 (12.82) <0.001
Yes 557 (62.03) 341 (37.97) 252 (55.26) 204 (44.74) 305 (69.00) 137 (31.00)
Depressive symptoms
No 793 (69.93) 341 (30.07) 0.047 337 (60.18) 223 (39.82) 0.702 456 (79.44) 118 (20.56) <0.01
Yes 233 (64.36) 129 (35.64) 93 (58.49) 66 (41.51) 140 (68.97) 63 (31.03)
Health perception
Good 829 (72.98) 307 (27.02) <0.001 361 (64.35) 200 (35.65) <0.001 468 (81.39) 107 (18.61) <0.001
Not good 197 (54.72) 163 (45.28) 69 (43.67) 89 (56.33) 128 (63.37) 74 (36.63)
Values are: numbers (%) for categorical variables and means± standard deviation for continuous variables.
Depressive symptoms is based on the score of the Patient Health Questionnaire (PHQ-9 ≥5). Percentages do not include missing values; missing values range from 1 to 7 observations for all variables except for
prediabetes (60 missing values) and hypercholesterolemia (49 missing values).
BMI=body mass index, EHES-LUX=European Health Examination Survey in Luxembourg, EU=European Union.
∗
Chi-square test for categorical variables, t test for continuous variables.
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Figure 2. Total residual spatial effects (red: high risk; green: low risk) and 95% posterior probability map on hypertension prevalence in Luxembourg (gray: no
signiﬁcant effect; black: signiﬁcant positive spatial effect; white: signiﬁcant negative spatial effect) by cantons (A) and communes (B). Total and stratiﬁed by sex (total
A.1 and B.1; men A.1.1 and B.1.1; women A.1.2 and B.1.2): EHES-LUX (N=1497). EHES-LUX=European Health Examination Survey in Luxembourg.
Ruiz-Castell et al. Medicine (2016) 95:36 Medicinedrinking alcohol every day had a protective effect from
hypertension, an association not observed in the marginal model.4. Discussion
Results from this study conﬁrm that hypertension is still a major,
neglected public health issue in Luxembourg where this condition
affects about a third of the population, with possibly 70% of
hypertensive patients being either unaware of their status or
inadequately controlled. This means that approximately 69,000
residents of Luxembourg, aged 25 to 64 years, may be unaware
that they are suffering from hypertension or are not sufﬁciently
controlled (see Figure, Supplemental Content 3, http://links.lww.
com/MD/B251). Although the prevalence of hypertension
remains high, compared with a previous study conducted in
2007 to 2008, awareness and control by treatment have
improved from 40% to 55.4% and from 30% to 57%,
respectively.[20] Such a temporal tendency of rate reduction in
blood pressure and hypertension has been also observed in other
high-income countries such as England, Germany, Canada, and
the USA.[26–28] Still, Luxembourg is far from achieving adequate
levels of awareness and control.[28–30]
As observed in other studies, hypertension increases with age
and BMI, and differs by sex—males are usually more likely to be
hypertensive than females.[31] High levels of physical activity
were associated with lower risk of hypertension, especially in6men. These observations are consistent with studies supporting
the positive effects of diet and physical activity on hyperten-
sion.[6] Notwithstanding the importance of these studies, we did
not observe an effect of fruit and vegetables consumption in our
data. Nevertheless, it may be interesting to analyze other aspects
of diet and cultural differences in food intake, such as salt and
sugar consumption, both known for their high inﬂuence on
hypertension.[32] Differences were also observed regarding job
status, with a higher prevalence of hypertensive patients
associated with unemployment status. Social inequalities in
health outcomes are observed in all European countries, even in
those with historically better policies of social-security protec-
tion, with larger differences in cardiovascular mortality in
northern European countries compared with those in the
South.[31,33] Reasons accounting for such inequalities include
differences in the prevalence of cardiovascular risk factors, such
as smoking, alcohol consumption, and/or diet, across socioeco-
nomic groups. With regard to alcohol consumption, sex
differences were observed in our study, with a beneﬁcial effect
for hypertension inmen only. The role of alcohol consumption on
cardiovascular health is complex, with a protective effect in low-
to-moderate regular consumers and an increased risk in heavy
drinkers.[34] It may be different depending on the speciﬁc health
outcome and mediated by drinking patterns.[9]
Recent evidence suggests the role of psychosocial factors
(e.g., occupational stress, mental health, sleep quality) in the
Table 3
Marginal and posterior odds ratios of hypertension across covariates (EHES-LUX [N=1497]).
Hypertension
∗
Hypertension†
Total Men Women Total Men Women
OR (95% CI) OR (95% CI) OR (95% CI) POR (95% CR) POR (95% CR) POR (95% CR)
Age, y 1.07 (1.05, 1.08) 1.06 (1.03, 1.08) 1.09 (1.06, 1.11)
Sex
Men 1.00 1.00
Women 0.39 (0.29, 0.52) 0.39 (0.28, 0.52)
BMI, kg/m2
<25 1.00 1.00 1.00 1.00 1.00 1.00
25–30 2.07 (1.52, 2.83) 2.38 (1.55, 3.65) 1.92 (1.21, 3.05) 2.01 (1.54, 2.78) 2.40 (1.62, 3.73) 2.00 (1.30, 3.29)
≥30 5.59 (3.94, 7.92) 8.13 (4.82, 13.70) 4.03 (2.44, 6.67) 5.62 (4.15, 8.27) 9.16 (5.23, 15.72) 4.47 (2.55, 8.18)
Country of birth
Luxembourg 1.00 1.00 1.00 1.00 1.00 1.00
Portugal 0.65 (0.41, 1.03) 0.74 (0.41, 1.33) 0.67 (0.34, 1.35) 0.66 (0.44, 1.00) 0.78 (0.45, 1.51) 0.65 (0.34, 1.13)
Other EU countries 0.80 (0.57, 1.12) 0.59 (0.36, 0.94) 1.42 (0.88, 2.29) 0.91 (0.67, 1.23) 0.57 (0.37, 0.97) 1.43 (0.89, 2.36)
Other non-EU countries 1.08 (0.68, 1.73) 0.98 (0.53, 1.81) 1.60 (0.77, 3.32) 1.20 (0.78, 1.76) 0.94 (0.50, 1.75) 1.56 (0.64, 3.26)
Education
Primary 1.00 1.00 1.00 1.00 1.00 1.00
Secondary 1.00 (0.69, 1.45) 1.18 (0.72, 1.95) 0.86 (0.51, 1.42) 1.02 (0.71, 1.61) 1.26 (0.72, 2.27) 0.86 (0.53, 1.34)
Tertiary 1.11 (0.73, 1.68) 1.63 (0.93, 2.86) 0.64 (0.34, 1.21) 1.08 (0.69, 1.61) 1.81 (0.98, 3.36) 0.66 (0.34, 1.18)
Job status
Not working 1.00 1.00 1.00 1.00 1.00 1.00
Working 0.71 (0.50, 0.99) 0.72 (0.42, 1.21) 0.69 (0.44, 1.08) 0.74 (0.52, 1.04) 0.66 (0.42, 1.08) 0.76 (0.47, 1.21)
Marital status
Single 1.00 1.00 1.00 1.00 1.00 1.00
Married or in a civil union 1.02 (0.77, 1.35) 1.11 (0.75, 1.65) 0.91 (0.60, 1.38) 1.00 (0.75, 1.26) 1.13 (0.77, 1.73) 0.92 (0.62, 1.35)
Smoking
Never smoke 1.00 1.00 1.00 1.00 1.00 1.00
Ex-smokers 0.96 (0.70, 1.33) 0.99 (0.64, 1.53) 0.89 (0.55, 1.45) 0.96 (0.68, 1.32) 0.97 (0.56, 1.46) 0.92 (0.48, 1.41)
Occasionally 0.63 (0.33, 1.20) 0.68 (0.31, 1.47) 0.54 (0.13, 2.21) 0.62 (0.30, 1.20) 0.69 (0.30, 1.92) 0.43 (0.08, 1.79)
Everyday 0.71 (0.49, 1.02) 0.71 (0.43, 1.18) 0.78 (0.44, 1.36) 0.75 (0.55, 1.07) 0.66 (0.41, 1.14) 0.77 (0.44, 1.39)
Alcohol (last year)
Never 1.00 1.00 1.00 1.00 1.00 1.00
Ex-drinkers 1.07 (0.45, 2.55) 0.17 (0.03, 0.87) 2.32 (0.91, 5.90) 1.23 (0.59, 2.37) 0.14 (0.03, 0.59) 2.36 (0.76, 5.32)
Drink alcohol irregularly 0.78 (0.43, 1.42) 0.33 (0.10, 1.01) 1.18 (0.60, 2.35) 0.85 (0.48, 1.52) 0.27 (0.08, 0.73) 1.25 (0.61, 2.81)
Drink alcohol regularly 0.72 (0.40, 1.30) 0.30 (0.10, 0.92) 1.10 (0.56, 2.17) 0.80 (0.51, 1.38) 0.25 (0.08, 0.65) 1.11 (0.51, 2.41)
Drink alcohol everyday 0.98 (0.50, 1.91) 0.40 (0.12, 1.33) 1.63 (0.66, 4.00) 1.12 (0.58, 1.80) 0.33 (0.10, 0.83) 1.65 (0.53, 4.33)
Physical activity
Never 1.00 1.00 1.00 1.00 1.00 1.00
3h/wk 0.86 (0.63, 1.19) 0.84 (0.54, 1.32) 0.96 (0.60, 1.52) 0.91 (0.65, 1.26) 0.84 (0.56, 1.34) 0.95 (0.62, 1.51)
>3h/wk 0.69 (0.49, 0.97) 0.64 (0.41, 1.00) 0.76 (0.44, 1.32) 0.74 (0.52, 1.06) 0.60 (0.37, 0.92) 0.72 (0.39, 1.17)
Sleep duration (not work days), h
7–8 1.00 1.00 1.00 1.00 1.00 1.00
6 1.21 (0.81, 1.81) 1.24 (0.71, 2.18) 1.15 (0.67, 1.97) 1.17 (0.83, 1.65) 1.25 (0.67, 2.02) 1.07 (0.62, 2.05)
≥9 1.33 (0.98, 1.82) 1.33 (0.87, 2.02) 1.35 (0.85, 2.16) 1.29 (0.97, 1.81) 1.27 (0.85, 1.86) 1.38 (0.92, 2.35)
Depressive symptoms
No 1.00 1.00 1.00 1.00 1.00 1.00
Yes 1.36 (1.00, 1.86) 1.12 (0.74, 1.72) 1.75 (1.11, 2.77) 1.42 (1.04, 1.85) 1.19 (0.78, 1.81) 1.83 (1.27, 2.68)
Health perception
Good 1.00 1.00 1.00 1.00 1.00 1.00
Not good 1.41 (1.01, 1.95) 1.67 (1.04, 2.70) 1.25 (0.78, 1.99) 1.48 (1.07, 2.10) 1.63 (1.01, 2.69) 1.27 (0.81, 1.92)
95% CI=95% conﬁdence interval, BMI=body mass index, CR= credible region, OR= odds ratio, POR=posterior odds ratio.
∗
Adjusted marginal OR from standard logistic regression models (N=1497) stratiﬁed by men (n=722) and women (n=786).
† Adjusted posterior OR from Bayesian geo-additive regression models after controlling for age, covariates, and communes stratiﬁed by sex.
Ruiz-Castell et al. Medicine (2016) 95:36 www.md-journal.comdevelopment of hypertension. We observed a higher prevalence
of hypertension in men with poor health perception and women
with depressive symptoms. Studies that analyzed the role of
depression in hypertension obtained mixed ﬁndings, suggesting
the complexity of the matter and the need for additional
prospective studies with standardizedmeasures of depression and
similar age range of participants to be compared between
studies.[14] It would seem that the alteration in the normal7function of the autonomic nervous, through an increase in the
sympathetic activity, could be related to the observed association
between depression and hypertension.[35] Licht et al[36] suggested
that the increase in blood pressure could be due to certain
antidepressant medication, but when we adjusted by depression
medication (data not shown), the association of depressive
symptoms and hypertension remained the same, removing the
possibility of a confounder effect of medication. The sex-speciﬁc
Ruiz-Castell et al. Medicine (2016) 95:36 Medicineassociation of depressive symptoms with hypertension risk,
among women only, is a novel observation which will deserve
further investigations.
Evidences suggest the importance of multilevel predictors of
health that include individual-level and geographic patterns to
better understand the burden of major chronic conditions such as
hypertension.[37,38] This could add the socioeconomic, cultural,
or environmental dimension not explained by individual
characteristics. In our analysis, we observed a geographic
variation in hypertension prevalence in Luxembourg across
cantons and communes. The highest risk of hypertension was
observed in the South-Western region of the country, one of the
most industrialized regions in Luxembourg known for decades as
a focus of industrial and mining activities. The region was the
most economically affected by the crisis in the steel industry in the
1970s.[39,40] Possible explanations for the different geographic
patterns could be due to individual risk factors, together with the
presence of socioeconomic disparities between regions, demo-
graphic or cultural differences, and/or the inﬂuence of variations
in environmental factors. Lord and Gerber[41] revealed a similar
distribution in socioeconomic inequalities by communes in
Luxembourg. They observed the most favorable conditions in
the capital and the immediate suburban outskirts where the
highest qualiﬁed immigrants also concentrate, comparing with
the south of the Grand Duchy, which is populated by less
qualiﬁed immigrants (EU and non-EU).[41] Those inequalities
could explain, at least partially, the geographic distribution in
hypertension prevalence in our study. Other explanations could
be due to the potential effect of environmental exposures, such as
air pollution and/or noise, both associated with risk of
hypertension.[41–43] To our knowledge, this is the ﬁrst popula-
tion-based study in Europe providing geographical analyses of
hypertension prevalence at regional and local level within a
country, by controlling for individual risk factors.
A limitation of our study was the low participation rate, a
common challenge for population-based studies, relying on
randomly selected samples. The sample was representative of the
population of Luxembourg on sex, age, and district of residence,
but we could not ascertain if there was a nonresponse selection
bias when comparing health status, socioeconomic position, and
nationality. In addition, it should be noted that several landmark
epidemiological studies in hypertension research are based on
highly selected samples, often taken from occupational settings,
and hence prone to selection bias. Regarding lifestyle character-
istics, we did not measure quantity of alcohol consumption nor
different drinking patterns, and thus we could not account for
them. The effect of alcohol consumption on hypertension may
be different depending on the amount of alcohol and if the
consumptionwaswith orwithout food consumption. Assessment
of physical activity, alcohol consumption, smoking, and fruits
and vegetables intake was based on self-report and did not
include biological measurements or speciﬁc tests. This could
generate amisclassiﬁcation of lifestyle characteristics due to recall
bias. We did not have information on other risk factors of
hypertension such as serum uric acid or salt consumption and
therefore could not account for their potential effect.[44,45]
Finally, the cross-sectional nature of the study does not allow us
to infer causal associations.
Even in a small high-income country such as Luxembourg, we
observed individual and geographic differences in hypertension
prevalence. It is therefore necessary to consider the role of both
individual and regional risk factors in hypertension prevalence,
and also public health initiatives to control and promote8awareness about this condition to reduce its burden in
Luxembourg. Future studies should include information on
environmental exposures and socioeconomic disadvantage at
different levels (individual, regional) to better understand
geographic variations of hypertension, as observed in the current
study.Acknowledgments
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